AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get smart everyday buys delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Sobi’s Nomination Committee has proposed Börje Ekholm for election as a board member and chair at the company’s 2027 Annual General Meeting. Current Chair David Meek will remain in the role through May 2027 and has decided not to stand for re-election.

Sobi’s Nomination Committee has proposed that Börje Ekholm be elected as a board member and chair at the company’s 2027 Annual General Meeting, after current Chair David Meek told the committee he will not stand for re-election. Meek is expected to continue as chair through the end of his current term in May 2027, so the proposed change is not immediate.

The proposal concerns two positions: Ekholm would join the board of Swedish Orphan Biovitrum, known as Sobi, and take over as its chair if shareholders elect him at the 2027 AGM. The committee’s complete proposals are due to be published before the meeting. The announcement does not state a date for the AGM or provide further details of the nomination process.

Meek has served as a Sobi board member and chair since December 2024. The company said he will remain in the role for the rest of his term, through May 2027. Sobi’s announcement credited the company’s performance during his tenure, citing growth and shareholder returns, wider access to medicines through new launches and indication extensions, and a stronger clinical development pipeline. Those descriptions are the company’s account of its performance.

Ekholm brings more than 30 years of experience in technology, investment management and international business leadership, according to Sobi. He recently stepped down as chief executive of Ericsson, and previously led Patricia Industries and Investor AB. He is currently chair of Trimble and is due to join Nasdaq Inc.’s board on November 1, 2026. His earlier board roles include Alibaba, Husqvarna, Nasdaq, Scania and WM Data.

At a glance
announcementWhen: Announced October 29, 2026; proposed el…
The developmentSobi’s Nomination Committee proposed Börje Ekholm as its next board chair and board member at the 2027 AGM, following David Meek’s decision not to seek another term.

A Board Handover at Sobi

The proposal would put a chair with experience across global companies and investment ownership at the head of Sobi’s board, subject to a shareholder vote. Board chairs lead the work of the board, which oversees company strategy and management; the announcement does not describe any change to Sobi’s executive leadership or day-to-day operations.

Ekholm also has a past connection to Sobi through his work at Investor AB. The company said he was involved in the creation of Sobi through the merger of Biovitrum and Swedish Orphan International and worked with the company from an owner’s perspective. That history gives him familiarity with the business, although the announcement does not set out a new strategy or explain how he would approach the chair role.

The timing leaves a transition period of several months: Meek remains chair until May 2027, while the proposed election is scheduled for the 2027 AGM. Sobi reported SEK 28 billion in revenue for 2025 and said it had about 2,000 employees across several regions, placing the board appointment at a company with a sizable international operation. These company-reported figures describe its scale, not the expected effect of the nomination.

Products Worth Considering

Brother TD-2020A 2‑Inch Direct Thermal Desktop Label Printer with USB

Brother TD-2020A 2‑Inch Direct Thermal Desktop Label Printer with USB

As an affiliate, we earn on qualifying purchases.

Ekholm’s Earlier Sobi Connection

Sobi is a biopharmaceutical company focused on medicines for people living with rare diseases. Its shares trade on Nasdaq Stockholm. The nomination announcement is a governance development rather than a report of a product launch, financial result or change in ownership.

Ekholm’s connection to the company predates the proposed appointment. Sobi said he was involved in its formation during his tenure as CEO of Investor AB, when Biovitrum and Swedish Orphan International merged. The committee cited both this familiarity and his international leadership and board experience in explaining its choice.

The departure timetable was also stated in the announcement: Meek, who became chair in December 2024, will serve through May 2027 and will not seek re-election. The committee’s proposal is therefore for a successor to be considered at the next annual meeting, not for Ekholm to take over immediately.

Shareholder Vote Still Ahead

Ekholm has been proposed, not elected. Shareholders will decide at the 2027 AGM whether to elect him as a board member and chair. Sobi has not yet published the committee’s complete proposals, the meeting date, or further information about the voting process in this announcement.

The announcement also does not describe Ekholm’s intended priorities as chair, any changes to Sobi’s board composition beyond this proposed appointment, or how responsibilities will be handled between the announcement and the AGM. No outcome of the shareholder vote can be assumed at this stage.

Nomination Details Before the AGM

Sobi’s Nomination Committee said its complete proposals will be published in due time before the 2027 AGM. Those materials are expected to provide further formal details for shareholders ahead of the meeting, where the proposed board appointments will be considered.

Until then, Meek is set to remain chair through May 2027, according to the announcement. The key next milestones are publication of the full nomination proposals and the shareholder vote at the AGM; Sobi has not stated the meeting’s date in the material provided.

Key Questions

Who has Sobi proposed as its next board chair?

Sobi’s Nomination Committee proposed Börje Ekholm for election as a board member and chair at the 2027 AGM.

Has Ekholm been elected?

No. He is a nominee, and shareholders are expected to consider the proposal at the 2027 Annual General Meeting.

When will David Meek leave the chair role?

Meek said he will not stand for re-election. Sobi says he will remain chair for the rest of his current term, through May 2027.

What experience does Ekholm bring to Sobi?

Sobi cited more than 30 years of experience in technology, investment management and international business leadership. He recently stepped down as Ericsson CEO, previously led Investor AB and Patricia Industries, and has served on several company boards.

Source: prnewswire.com

This content is for general information only and is not financial, tax or legal advice. Consult a qualified professional for decisions about your money.
You May Also Like

Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals For Their Shareholders?

Halper Sadeh says it is investigating proposed transactions involving RXO, PTC, Lifecore and WaFd; no findings of wrongdoing are stated.

Florida Credit Union To Buy 2Nd Bank In A Month

Pensacola-based Gulf Winds Credit Union has agreed to buy Peoples Exchange Bank, its second whole-bank deal in about a month. Terms were not disclosed.

Glencore Gets RIGI Nod For $4B Argentina Copper Project

Argentina approved Glencore’s MARA project for RIGI investment incentives. The decision does not amount to a final construction approval.

Invitation To Bid For 3-Months Bills Of The European Stability Mechanism (ESM)

The Bundesbank lists an ESM invitation to bid for three-month bills, but the supplied notice does not state auction dates, amounts or terms.